A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

Clinical trial NCT00040677 · COMPLETED

Trial details

NCT number: NCT00040677
Sponsor: Icagen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anemia

Start date: 2002-02-01
Primary completion: 2003-11-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.